Back
Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
37
GMAB
Genmab AS
Last Price:
27.51
Seasonality Move:
8.67%
Sell
9
ASND
Ascendis Pharma AS
Last Price:
119.16
Seasonality Move:
8.16%
Sell
37
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GMAB] share price is $27.50. The Score for GMAB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $119.18. The Score for ASND is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GMAB Stock Price Chart
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $119.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight selling pressure.
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 51.6 | Buy |
Chaikin Money Flow: | -292698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.66 - 27.76) | Buy |
Bollinger Bands (100): | (26.32 - 28.86) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.49 | Sell |
Relative Strength Index (14 RSI): | 27.11 | Sell |
Chaikin Money Flow: | -43957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (125.52 - 140.28) | Sell |
Bollinger Bands (100): | (127.71 - 139.79) | Sell |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.68 | Sell |
20-day SMA: | 27.3 | Buy |
50-day SMA: | 27.01 | Buy |
200-day SMA: | 28.8 | Sell |
8-day EMA: | 27.57 | Sell |
20-day EMA: | 27.44 | Buy |
50-day EMA: | 27.35 | Buy |
200-day EMA: | 29.2 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 130.81 | Sell |
20-day SMA: | 134.52 | Sell |
50-day SMA: | 134.36 | Sell |
200-day SMA: | 134.06 | Sell |
8-day EMA: | 127.79 | Sell |
20-day EMA: | 132.04 | Sell |
50-day EMA: | 133.51 | Sell |
200-day EMA: | 129.66 | Sell |
Genmab AS Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.11 per share, an increase this year of $0.07 per share, and an increase next year of $0.33 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $1.47 per share, an increase this year of $2.03 per share, and an increase next year of $4.16 per share.
Genmab AS Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |